DXB ASX Chart
Snapshot
Dimerix Limited (DXB) is a clinical-stage biopharmaceutical company focused on improving the lives of patients with inflammatory diseases, including kidney disease. The company is developing its proprietary Phase 3 product candidate DMX-200 for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and DMX-700 for orphan respiratory / renal Disease. Both DMX-200 and DMX-700 were identified using Dimerix's proprietary assay, Receptor Heteromer Investigation Technology (Receptor-HIT), a scalable and globally applicable technology platform that enables the understanding of receptor interactions to rapidly screen and identify new drug opportunities.
Share Price Activity (ASX)
| Last (Price) | |
| Change | 0.00 (0.00) |
| Bid / Ask | - |
| Volume | |
| Volume (4w avg) | |
| Turnover | |
| Open | |
| Day Range | - |
| VWAP | |
| Prev Close | |
| Last Trade |
Performance
| 1 Week | |
| 1 Month | |
| 2026 YTD | |
| 1 Year | |
| vs Sector (1yr) | -20.44% |
| vs ASX 200 (1yr) | -58.89% |
Announcements
Corporate Overview
Corporate Details
| Head Office | Fitzroy VIC 3065 |
| Website | www.dimerix.com |
| Registry | Automic Group |
| Auditor | Stantons International Audit and Consulting Pty Ltd |
| Date Listed | 4 Feb 1993 |
Upcoming Calendar (Forecasted)
| Date | Event |
|---|---|
| 27/08/2026 | Report (Prelim) |
| 27/08/2026 | Report (Annual) |
| 25/02/2027 | Report (Interim) |
Former Company Names
- Sun Biomedical Limited (SBN), 30/11/2015
- Harrington Group Limited (HGR), 18/12/2007
- Ausfor Limited (ASF), 09/05/1997
- Pine Forests of Australia [Orange] Limited, 06/12/1988
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
DXB directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of DXB directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
| Name | Last Notice | Total Shares | Shares Held (%) |
|---|---|---|---|
| Skiptan Pty Ltd ATFT P&M Meurs Family Trust | 18/08/2025 | 36,865,281 | 6.14 |
| Mr Peter Meurs | 18/08/2025 | 40,018,964 | 6.67 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
| Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
Historical Data
| Year | Closing Price | Last Trade |
|---|---|---|
| 2025 | $0.575 | 30 June |
| 2024 | $0.51 | 28 June |
| 2023 | $0.062 | 30 June |
| 2022 | $0.12 | 30 June |
| 2021 | $0.195 | 30 June |
| 2020 | $0.35 | 30 June |
| 2019 | $0.085 | 28 June |
| 2018 | $0.095 | 29 June |
| 2017 | $0.01 | 30 June |
| 2016 | $0.007 | 30 June |
| 2015 | $0.01 | 30 June |
| 2014 | $0.007 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.